US Stock MarketDetailed Quotes

Jasper Therapeutics (JSPR)

Watchlist
  • 0.9373
  • +0.0172+1.87%
Trading May 14 10:24 ET
26.24MMarket Cap-0.24P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jasper Therapeutics (JSPR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-23.26%-77.16M
-3.47%-21.87M
-20.97%-17M
-32.30%-15.45M
-45.16%-22.84M
-20.23%-62.6M
-28.25%-21.13M
-17.29%-14.05M
12.00%-11.68M
-52.26%-15.74M
Net income from continuing operations
-6.36%-75.8M
62.58%-9.1M
-0.53%-18.74M
-83.25%-26.72M
-54.73%-21.24M
-10.55%-71.27M
-46.68%-24.32M
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
Operating gains losses
----
----
----
----
----
-98.09%11K
----
----
----
----
Depreciation and amortization
-23.09%1.06M
18.37%290K
-57.67%229K
-13.71%258K
-3.13%279K
23.92%1.37M
-13.43%245K
96.01%541K
8.73%299K
5.11%288K
Other non cash items
-1,183.10%-5.32M
-4,791.54%-6.1M
118.40%273K
162.50%315K
66.38%193K
22.44%491K
54.76%130K
154.82%125K
137.74%120K
-86.56%116K
Change In working capital
-2,775.54%-4.92M
-1,255.58%-9.73M
-109.73%-187K
786.03%8.88M
-8.46%-3.88M
-96.39%184K
159.17%842K
-53.37%1.92M
-31.37%1M
-478.54%-3.58M
-Change in receivables
----
----
----
----
----
--0
--0
--0
--0
--0
-Change in prepaid assets
16.20%-1.78M
-22.35%-2.29M
52.82%-209K
3,382.14%919K
-192.20%-201K
-376.79%-2.12M
-167.14%-1.87M
-131.55%-443K
-107.93%-28K
175.17%218K
-Change in payables and accrued expense
-179.11%-2.18M
-352.65%-7.01M
-82.45%432K
699.80%8.05M
-4.88%-3.66M
-47.00%2.76M
491.68%2.78M
-15.66%2.46M
-4.46%1.01M
-558.08%-3.49M
-Change in other current assets
35.18%707K
-80.83%37K
-72.00%42K
30.77%340K
460.00%288K
189.55%523K
120.71%193K
341.18%150K
-7.14%260K
-335.29%-80K
-Change in other current liabilities
-71.63%-1.67M
-82.81%-468K
-83.00%-452K
-83.54%-435K
-35.19%-315K
-2.96%-973K
1.54%-256K
-4.66%-247K
-4.41%-237K
-4.95%-233K
Cash from discontinued investing activities
Operating cash flow
-23.26%-77.16M
-3.47%-21.87M
-20.97%-17M
-32.30%-15.45M
-45.16%-22.84M
-20.23%-62.6M
-28.25%-21.13M
-17.29%-14.05M
12.00%-11.68M
-52.26%-15.74M
Investing cash flow
Cash flow from continuing investing activities
100.94%5K
0
0
100.64%1K
116.00%4K
-99.25%-532K
66.96%-76K
-274K
-1,327.27%-157K
3.85%-25K
Net PPE purchase and sale
100.94%5K
--0
--0
100.64%1K
116.00%4K
-99.25%-532K
66.96%-76K
---274K
-1,327.27%-157K
3.85%-25K
Cash from discontinued investing activities
Investing cash flow
100.94%5K
--0
--0
100.64%1K
116.00%4K
-99.25%-532K
66.96%-76K
---274K
-1,327.27%-157K
3.85%-25K
Financing cash flow
Cash flow from continuing financing activities
-28.55%34.21M
-198.55%-340K
315,322.22%28.39M
3,304.97%6.16M
0
-52.58%47.88M
227.31%345K
-75.00%9K
159.34%181K
-53.36%47.35M
Net common stock issuance
-28.03%33.97M
--27.51M
--514K
--5.94M
--0
-53.49%47.2M
--0
--0
--0
-53.49%47.2M
Proceeds from stock option exercised by employees
-64.73%243K
-8,173.62%-27.85M
309,611.11%27.87M
23.20%223K
--0
52.43%689K
1,132.14%345K
-75.00%9K
-49.16%181K
381.25%154K
Cash from discontinued financing activities
Financing cash flow
-28.55%34.21M
-198.55%-340K
315,322.22%28.39M
3,304.97%6.16M
--0
-52.58%47.88M
227.31%345K
-75.00%9K
159.34%181K
-53.36%47.35M
Net cash flow
Beginning cash position
-17.47%72.05M
-44.77%51.32M
-62.77%39.93M
-58.60%49.22M
-17.47%72.05M
125.78%87.3M
-10.90%92.92M
-7.74%107.24M
-8.42%118.89M
125.78%87.3M
Current changes in cash
-181.61%-42.95M
-6.43%-22.21M
179.55%11.39M
20.31%-9.29M
-172.30%-22.84M
-131.35%-15.25M
-22.88%-20.87M
-19.86%-14.32M
14.22%-11.66M
-65.35%31.59M
End cash Position
-59.60%29.11M
-59.60%29.11M
-44.77%51.32M
-62.77%39.93M
-58.60%49.22M
-17.47%72.05M
-17.47%72.05M
-10.90%92.92M
-7.74%107.24M
-8.42%118.89M
Free cash flow
-22.19%-77.17M
-3.00%-21.87M
-18.66%-17M
-30.61%-15.46M
-44.93%-22.84M
-20.67%-63.15M
-27.06%-21.23M
-19.57%-14.33M
10.89%-11.84M
-52.12%-15.76M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -23.26%-77.16M-3.47%-21.87M-20.97%-17M-32.30%-15.45M-45.16%-22.84M-20.23%-62.6M-28.25%-21.13M-17.29%-14.05M12.00%-11.68M-52.26%-15.74M
Net income from continuing operations -6.36%-75.8M62.58%-9.1M-0.53%-18.74M-83.25%-26.72M-54.73%-21.24M-10.55%-71.27M-46.68%-24.32M-6.23%-18.64M9.31%-14.58M3.73%-13.73M
Operating gains losses ---------------------98.09%11K----------------
Depreciation and amortization -23.09%1.06M18.37%290K-57.67%229K-13.71%258K-3.13%279K23.92%1.37M-13.43%245K96.01%541K8.73%299K5.11%288K
Other non cash items -1,183.10%-5.32M-4,791.54%-6.1M118.40%273K162.50%315K66.38%193K22.44%491K54.76%130K154.82%125K137.74%120K-86.56%116K
Change In working capital -2,775.54%-4.92M-1,255.58%-9.73M-109.73%-187K786.03%8.88M-8.46%-3.88M-96.39%184K159.17%842K-53.37%1.92M-31.37%1M-478.54%-3.58M
-Change in receivables ----------------------0--0--0--0--0
-Change in prepaid assets 16.20%-1.78M-22.35%-2.29M52.82%-209K3,382.14%919K-192.20%-201K-376.79%-2.12M-167.14%-1.87M-131.55%-443K-107.93%-28K175.17%218K
-Change in payables and accrued expense -179.11%-2.18M-352.65%-7.01M-82.45%432K699.80%8.05M-4.88%-3.66M-47.00%2.76M491.68%2.78M-15.66%2.46M-4.46%1.01M-558.08%-3.49M
-Change in other current assets 35.18%707K-80.83%37K-72.00%42K30.77%340K460.00%288K189.55%523K120.71%193K341.18%150K-7.14%260K-335.29%-80K
-Change in other current liabilities -71.63%-1.67M-82.81%-468K-83.00%-452K-83.54%-435K-35.19%-315K-2.96%-973K1.54%-256K-4.66%-247K-4.41%-237K-4.95%-233K
Cash from discontinued investing activities
Operating cash flow -23.26%-77.16M-3.47%-21.87M-20.97%-17M-32.30%-15.45M-45.16%-22.84M-20.23%-62.6M-28.25%-21.13M-17.29%-14.05M12.00%-11.68M-52.26%-15.74M
Investing cash flow
Cash flow from continuing investing activities 100.94%5K00100.64%1K116.00%4K-99.25%-532K66.96%-76K-274K-1,327.27%-157K3.85%-25K
Net PPE purchase and sale 100.94%5K--0--0100.64%1K116.00%4K-99.25%-532K66.96%-76K---274K-1,327.27%-157K3.85%-25K
Cash from discontinued investing activities
Investing cash flow 100.94%5K--0--0100.64%1K116.00%4K-99.25%-532K66.96%-76K---274K-1,327.27%-157K3.85%-25K
Financing cash flow
Cash flow from continuing financing activities -28.55%34.21M-198.55%-340K315,322.22%28.39M3,304.97%6.16M0-52.58%47.88M227.31%345K-75.00%9K159.34%181K-53.36%47.35M
Net common stock issuance -28.03%33.97M--27.51M--514K--5.94M--0-53.49%47.2M--0--0--0-53.49%47.2M
Proceeds from stock option exercised by employees -64.73%243K-8,173.62%-27.85M309,611.11%27.87M23.20%223K--052.43%689K1,132.14%345K-75.00%9K-49.16%181K381.25%154K
Cash from discontinued financing activities
Financing cash flow -28.55%34.21M-198.55%-340K315,322.22%28.39M3,304.97%6.16M--0-52.58%47.88M227.31%345K-75.00%9K159.34%181K-53.36%47.35M
Net cash flow
Beginning cash position -17.47%72.05M-44.77%51.32M-62.77%39.93M-58.60%49.22M-17.47%72.05M125.78%87.3M-10.90%92.92M-7.74%107.24M-8.42%118.89M125.78%87.3M
Current changes in cash -181.61%-42.95M-6.43%-22.21M179.55%11.39M20.31%-9.29M-172.30%-22.84M-131.35%-15.25M-22.88%-20.87M-19.86%-14.32M14.22%-11.66M-65.35%31.59M
End cash Position -59.60%29.11M-59.60%29.11M-44.77%51.32M-62.77%39.93M-58.60%49.22M-17.47%72.05M-17.47%72.05M-10.90%92.92M-7.74%107.24M-8.42%118.89M
Free cash flow -22.19%-77.17M-3.00%-21.87M-18.66%-17M-30.61%-15.46M-44.93%-22.84M-20.67%-63.15M-27.06%-21.23M-19.57%-14.33M10.89%-11.84M-52.12%-15.76M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.20%
Sample Name
Sample Code
 +14.73%
Sample Name
Sample Code
 +13.75%
4
United States Oil Fund LP
USO
+12.98%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+10.80%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.04%
Sample Name
Sample Code
 +10.18%
Sample Name
Sample Code
 +10.03%
4
Hesai
HSAI
+6.91%
5
NIO Inc
NIO
+6.90%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -